Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SanBio Co Ltd (4592 JP)
Watchlist
25
Analysis
Health Care
•
Japan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
31 Jul 2024 14:30
Sanbio Obtains Marketing Approval For“Akuugo (R) Suspension For Intracranial Implantation”
Attachment
Exchange Announcement •
29 Jul 2024 17:00
Partial Revision To The “Notice Concerning Notice Of Allowance Of New Patent For Cell Therapy Using Sb623 For Chronic Ischemic Stroke In The Us”
Attachment
Exchange Announcement •
29 Jul 2024 14:00
[Delayed] Notice Concerning Notice Of Allowance Of New Patent For Cell Therapy Using Sb623 For Chronic Ischemic Stroke In The Us
Attachment
Exchange Announcement •
10 Jul 2024 09:30
[Delayed] [Results Of Basic Research] Publication Of An Article On The Neuronal Activity And Network Formation Promotion Of Sb623
Attachment
Exchange Announcement •
27 Jun 2024 14:00
[Delayed] Further Update On Regarding Reports On “Akuugo Suspension For Intracranial Implantation”
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.2
x